Hong Kong International Medical and Healthcare Fair 16-18 May 2023 HKCEC Booth no. 3E-E28
Detail
Eye Care Webinar 30 May 2023
Detail

DNA VACCINE

PLATFORM

Learn More

ANTI-Δ42PD1

ANTIBODY PLATFORM

Learn More
pipeline-photo

PIPELINE

Learn More
shutterstock_607718810

ABOUT

IMMUNO CURE

Immuno Cure is a biotechnology group based in the Hong Kong Science Park, focusing on research and development of immunotherapies for cancers, inflammatory and infectious diseases based on its patented PD-1-enhanced DNA vaccine and Anti-Δ42PD1 Antibody Immune Blocking technology platforms; with 2 vaccines in first-in-human clinical trials.

Learn More